KBI Biopharma

KBI Biopharma is a global CDMO providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. As a global leader in mammalian cell line development, with highly specialized solutions, KBI enables the life sciences industry to rapidly discover, develop, and commercialize innovative medicines and vaccines. KBI works closely to personalize and rapidly accelerate drug development programs.

Category
Clinical stage development company
Title of the presentation
Cultivating innovation: Growing the future of Cell Line Development
Speaker information
Name Position Institution
Severine Fagete Vice President, Cell Line Services KBI Biopharma